Stay updated on CR845 for Atopic Dermatitis Pruritus: Clinical Trial
Sign up to get notified when there's something new on the CR845 for Atopic Dermatitis Pruritus: Clinical Trial page.

Latest updates to the CR845 for Atopic Dermatitis Pruritus: Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check57 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of difelikefalin (CR845) for treating moderate to severe pruritus in adults with atopic dermatitis, and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference16%
Stay in the know with updates to CR845 for Atopic Dermatitis Pruritus: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CR845 for Atopic Dermatitis Pruritus: Clinical Trial page.